Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 4,794 shares at $53.68 ($257K) on 2019-02-28, disclosed to the SEC on 2019-03-01.
Open-market sale of $257k NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.68 | 2,397 | $129K | 50.0% |
| 2 | $53.68 | 2,397 | $129K | 50.0% |
| Total | $53.68 avg | 4,794 | $257K | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |